RE:RE:0.10
EthanDTrader wrote: Traders have to risk or miss out. Like majority here I'm also looking forward to the uplisting. It's impact may not be immediate but my brain figure it will be positive
I don't know why anyone would look forward to the uplisting. You won't find any Investor, fund manager, investment broker, etc in this whole world that can't invest in a company on the venture. There is nothing holding them back from investing other than the lack of future profit. The uplisting won't change interest.
Datametrex is a company that produces dilution more than profit. Insiders can buy shares, the company can buy back 5% shares, medicalls +10 customers a month lol, 40mill Ai annual revenue(NOT)lol, exclusive rights to carry EVAR's electric jerry can to the elusive stranded EV motorists lmao, plus Covid test kit sales all together will never be enough to move the needle being held down by the over half a BILLION full dilution share count.
Management has spent the past 52 weeks throwing gasoline on the company and the only thing left to do now is light the match with a R/S.